Novarex Co Ltd
KOSDAQ:194700
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novarex Co Ltd
KOSDAQ:194700
|
KR |
Intrinsic Value
The intrinsic value of Novarex Co Ltd (194700) under the Base Case is 26 243.91 KRW per share. Compared with the current market price of 9 140 KRW, the stock appears Undervalued by 65% .
The intrinsic value is calculated using the DCF method. The model assumes net margin rises from 8.8% last year to 9.9% by 2031, above its five-year average of 8.1%. If net margin stayed at its five-year average of 8.1%, the estimate would be about ₩23,380. The value of the years after 2031 is tied to revenue, so margins count only until then.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Novarex Does
Novarex Co Ltd is a South Korean animal-health company that develops and makes vaccines, medicines, and diagnostic products used in livestock and other veterinary care. Its products are meant to prevent disease, treat animals, and help vets and farms detect infections early.
- Headquarters
- Korea KR
- IPO date
- Nov 14, 2018
Revenue & Expenses Breakdown
Novarex Co Ltd
Earnings Waterfall
Novarex Co Ltd
The intrinsic value for Novarex Co Ltd (194700) under the Base Case is 26 243.91 KRW.
Compared with the current market price of 9 140 KRW, the stock appears Undervalued by 65% .